Invesco Nasdaq Biotechnology ETF
Price through Oct 2 · Flows through Oct 1. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET +$12M OVER THIS RANGE
Money keeps arriving — +$12M of net inflows over the past month, about 11.6% of the fund's asset base, while the price has returned +21.0% so far this year. At 0.19% a year, no lower reported fee appears among the alternatives shown here.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GILDGILEAD SCIENCES | 8.24% | $144.74 | -1.9% | ||
| 2 | AMGNAMGEN | 7.75% | $403.04 | -1.0% | ||
| 3 | VRTXVERTEX PHARMACEUTICALS | 7.61% | $504.73 | -0.4% | ||
| 4 | MRNAMODERNA | 5.05% | $190.01 | +0.6% | ||
| 5 | REGNREGENERON PHARMACEUTICALS | 4.97% | $735.20 | +0.1% | ||
| 6 | RVMDREVOLUTION MEDICINES | 2.95% | $206.64 | +0.4% | ||
| 7 | ILMNILLUMINA | 2.69% | $273.04 | +2.8% | ||
| 8 | BIIBBIOGEN | 2.20% | $219.88 | -1.3% | ||
| 9 | ALNYALNYLAM PHARMACEUTICALS | 2.07% | $219.72 | -5.0% | ||
| 10 | ROIVROIVANT SCIENCES | 1.72% | $35.72 | +0.6% | ||
| 11 | RPRXROYALTY PHARMA | 1.72% | $57.16 | -0.8% | ||
| 12 | ARGXARGENX SE | 1.71% | $919.21 | -1.8% | ||
| 13 | INSMINSMED | 1.59% | $111.12 | +2.3% | ||
| 14 | GHGUARDANT HEALTH | 1.57% | $177.80 | +1.7% | ||
| 15 | INCYINCYTE | 1.59% | $115.30 | -1.6% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 219| 1 week | -1.8% |
| 1 month | -5.3% |
| 3 months | +2.2% |
| 6 months | +18.6% |
| YTD | +21.0% |
| 1 year | +37.0% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$5M |
| 1 month | +$12M |
| 3 months | +$29M |
| YTD | +$48M |
| 1 year | +$48M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 8.2% of the book; the top ten carry 45%. Spread across 248+ names, it behaves like roughly 33 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $24M | $31M |
| TEM TEMPUS AI INC | $6M | $6M |
| IOVA IOVANCE BIOTHERAPEUTICS | $4M | $4M |
| IBRX IMMUNITYBIO | $4M | $3M |
| VRTX VERTEX PHARMACEUTICALS | $2M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IBBQ on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $882.6B | +$4.6B | -16bp on fee · 8351× the assets · +$4.6B in over the month | Head-to-head |
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -16bp on fee · 392× the assets · +$286M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.4B | +$187M | -17bp on fee · 89× the assets · +$187M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -16bp on fee · 172× the assets · +$199M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $56.2B | +$717M | -15bp on fee · 531× the assets · +$717M in over the month | Head-to-head |